|
EIF1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.11099999994858E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18149999953177E-07 |
| Normal-vs-Stage2 |
2.06889999999627E-05 |
| Normal-vs-Stage3 |
6.68099999767691E-08 |
| Normal-vs-Stage4 |
1.33609999952711E-07 |
| Stage1-vs-Stage2 |
7.463200E-01 |
| Stage1-vs-Stage3 |
3.222800E-01 |
| Stage1-vs-Stage4 |
3.773200E-01 |
| Stage2-vs-Stage3 |
7.320000E-01 |
| Stage2-vs-Stage4 |
6.946800E-01 |
| Stage3-vs-Stage4 |
9.177000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.90130000211309E-08 |
| Normal-vs-AfricanAmerican |
1.768260E-02 |
| Normal-vs-Asian |
7.64430000000926E-05 |
| Caucasian-vs-AfricanAmerican |
1.087170E-01 |
| Caucasian-vs-Asian |
3.328200E-01 |
| AfricanAmerican-vs-Asian |
4.273400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01540000244194E-08 |
| Normal-vs-Female |
1.9559999997476E-07 |
| Male-vs-Female |
1.776400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.48339999955982E-07 |
| Normal-vs-Age(41-60Yrs) |
5.57900003972378E-09 |
| Normal-vs-Age(61-80Yrs) |
2.10670000333479E-08 |
| Normal-vs-Age(81-100Yrs) |
9.581600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.332600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.722200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.270400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.608030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.302400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.733000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.366400E-02 |
| Classical-VS-Follicular |
1.232090E-02 |
| Classical-VS-Other |
7.956000E-01 |
| Classical-VS-Normal |
2.08999999995463E-06 |
| Tall-VS-Follicular |
9.746000E-01 |
| Tall-VS-Other |
6.049400E-01 |
| Tall-VS-Normal |
6.27520000406889E-08 |
| Follicular-VS-Other |
5.676800E-01 |
| Follicular-VS-Normal |
4.32850000287033E-09 |
| Other-VS-Normal |
4.048000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31299979169819E-10 |
| Normal-vs-N1 |
4.39630000181879E-08 |
| N0-vs-N1 |
2.399200E-01 |
|
|
